Company: HCTI
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026218
Chunk: 11

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 11
---
 of Directors, in its discretion, to amend our Amended and Restated Certificate of Incorporation to effect
a reverse stock split of our issued and outstanding Common Stock at a ratio of up to and including 250:1, such ratio to be determined
by the Board of Directors, including any increase in our authorized capital required in the event a fractional share will be created as
a result of the reverse stock split. On February 24, 2025, the majority stockholders of the Company approved the reverse stock split,
granting the Board of Directors the authority, without further action by the stockholders, to carry out such action, with the exact exchange
ratio and timing to be determined at the discretion of the Board of Directors. The Board of Directors may determine in its discretion
not to effect the reverse stock split and not to file any amendment to our Amended and Restated Certificate of Incorporation.  The
primary purpose for effecting the reverse stock split, should the Board of Directors choose to effect one, would be to increase the per
share price of our Common Stock to regain compliance with the minimum bid price requirement for continued listing set forth in Nasdaq
Listing Rule 5550(a)(2). 

On February 26, 2025, the Company received
a letter (the "Bid Price Deficiency Notice”) from Nasdaq notifying the Company that, because the closing bid price for its
common stock had been below $1.00 per share for 30 consecutive trading days, it was not compliant with the Minimum Bid Price Requirement.
In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), the Company had a period of 180 calendar days, or until August 25, 2025, to
regain compliance with the Minimum Bid Price Requirement. If at any time before August 25, 2025, the closing bid price of the Company’s
common stock closed at or above $1.00 per share for a minimum of 10 consecutive trading days (which number days may be extended by Nasdaq),
Nasdaq would provide written notification that the Company had achieved compliance with the Minimum Bid Price Requirement, and the matter
would be resolved.

10

Corporate Information

Our principal executive office is located at 7901
Stoneridge Drive, Suite 220, Pleasanton, CA 94588. Our telephone number is (925) 270-4812. Our website address is https://www.healthcaretriangle.com/.
The information